TISSUEMED
Tissuemed Ltd (Leeds, UK) has been granted regulatory approval of its TissuePatch™ range of ultra-thin surgical sealant films by the Chinese FDA (‘CFDA’).
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160601005413/en/
TissuePatch™ is the first and only synthetic sealant to be approved by the CFDA , giving Tissuemed sole access to a significant medical device market that is being driven by both an increase in income and a population greater than 1 billion, aging faster than any other country. Sales of medical devices in China have increased rapidly over the last decade, exceeding £30 billion in 2015.
The approval comes at the end of an exhaustive two and a half year programme and importantly covers all surgical applications for TissuePatch sealant film technology, allowing Tissuemed to extend its product reach beyond the traditional Neuro and Thoracic spaces.
Speaking about CFDA approval, Tissuemed’s CEO David Mandley said, ‘Approval of TissuePatch™ in China marks a major achievement for the company. This success opens the door to a significant market and is an exciting phase in the commercialisation of our innovative product range. With regulatory requirements in China becoming ever more challenging this approval is testament to Tissuemed’s proven technology and robust Quality System.’
‘We have a commercial partner in China with a proven track record of successfully introducing innovative products to address the demands of a rapidly growing healthcare system. Chinese surgeons will now be able to use our unique self-adhesive sealant film to prevent leaks after surgery, reducing post-operative complications and the need for extended hospital stay.’
For further information visit www.tissuemed.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160601005413/en/
Contact:
Tissuemed
Dr David Mandley
dmandley(@)tissuemed.com
+44
(0)113 2000500
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LENOVO25.4.2024 05:01:26 CEST | Press release
Global CIOs geared up to scale AI but organizations aren’t as ready
MUNDIPHARMA24.4.2024 22:02:28 CEST | Press release
Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area
MA-BEIGENE24.4.2024 22:02:28 CEST | Press release
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting
CA-TSMC24.4.2024 21:31:27 CEST | Press release
TSMC Celebrates 30th North America Technology Symposium with Innovations Powering AI with Silicon Leadership
NV-RIMINI-STREET-INC.24.4.2024 18:51:35 CEST | Press release
Rimini Street Appoints Steve Hershkowitz as Chief Revenue Officer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom